Mortality Rate and Associated Factors in Critically Ill Intubated Patients with Coronavirus Disease 2019 (COVID-19) at Pranangkloa Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220315003

Enrollment

Registered

2022-03-15

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exploration of demographics, mortality rate, clinical features, intubation practice, and anesthetic drug use in critically ill COVID-19 patients who received intubation. Anesthetics, Intubaion, Invasive ventilation, Coronavirus, COVID, Critical Illness, mortality

Interventions

critically ill patients who were intubated and survived at 30 days after intubation,critically ill patients who were intubated and deceased within 30 days after intubation

Treatment,Treatment

survival group,nonsuvival

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The critically ill patients with COVID-19 who were diagnosed with SARs-CoV-2 infection by real-time polymerase chain reaction (RT-PCR) method and underwent intubation, from April 1 to June 30, 2021

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
mortality rate 30 days percent	—

Secondary

Measure	Time frame
factors associated with mortality 30 days percent,anesthetic intubation practice 30 days frequency,anesthetic drugs use 30 days percent	—

Countries

Thailand

Contacts

Public ContactNatthika Yurakate

Pranangklao Hospital

natthika.yk@gmail.com0849988656

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026